Ava Lindqvist is 9.6 lb from the number she wrote down in September.

Tirzepatide, 26-week protocol. Everything below is measured, not estimated — the one modelled line on this page is drawn dashed and labelled as a projection.

Weight

214.6lb

−32.4 since intake

Body mass index

27.1kg/m²

−4.1, out of obese range

Adherence

96%

1 dose missed in 26 weeks

Waist

36.5in

−6.0 since intake

Fig. 1 — Weight, weeks 1 to 26

Recorded Mondays, 07:00, before food

Recorded weight, weekly Projected at the trailing 8-week rate Target corridor, 202–208 lb

Titration ladder

mg, weekly

2.5wk 1–4

5.0wk 5–8

7.5wk 9–16

10wk 17–26

12.5wk 27

15—

Held at 7.5 mg for four weeks in November after two nights of nausea. Escalation resumed once symptoms cleared for seven consecutive days.

Next injection: Thu 12 Mar10 mg · left thigh
Shipment: Fri 20 Mar4 pens, refrigerated
Review with clinician: Mon 23 Mar15 min, video
Labs re-drawn: Wk 32A1c, ALT, lipid panel

Fig. 2 — Daily check-ins, 26 weeks

Down a column is one week

Logged Missed Ahead

Bloodwork, drawn week 24

Ghost mark is the intake value

Marker	Latest	In range	Since intake
HbA1c	5.4%	4.0–5.6	−0.7
ALT	22U/L	7–56	−9
eGFR	98mL/min	> 90	+4
LDL	88mg/dL	< 100	−33
Resting HR	68bpm	55–95	−6

Ava Lindqvist is 9.6 lb from the number she wrote down in September.

Fig. 1 — Weight, weeks 1 to 26

Titration ladder

Fig. 2 — Daily check-ins, 26 weeks

Bloodwork, drawn week 24

MeridianClinical Readout